Safety and pharmacokinetics of extended use of palivizumab in Saudi Arabian infants and children

Saleh al-Alaiyan, Paul Pollack, Gerard F Notario

Article Type

Case Report

Published

The peak season of respiratory syncytial virus (RSV) infections in warmer climates may extend beyond the typical five-month RSV season of temperate regions. This study aimed to assess the safety, immunogenicity, and pharmacokinetics of an extended seven-dose regimen of palivizumab in children at high risk for serious infection by the RSV.

Read more

Willingness of European healthcare workers to undergo vaccination against seasonal influenza: current situation and suggestions for improvement

George Kassianos

Article Type

Case Report

Published

Uptake of vaccination against seasonal influenza in healthcare
workers (HCWs) is, in general, low (vaccine coverage of 6–54%), as is awareness of its importance, and has been decreasing in most European Union (EU) countries in recent years. This article clarifies the current situation and makes suggestions for improvement.

Read more

Vaccination against meningitis B: is it worth it?

Peter English

Article Type

Case Report

Published

When a new vaccine is licensed having passed the tests for efficacy and safety, governments who have to pay for it to be used, as in the UK, will carry out a careful economic appraisal before making it generally available. In this challenging article, Dr Peter English discusses whether or not a new vaccine for meningitis that has just been licensed and that could save lives is actually worth it.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.